Embed

Academic

Authors

Andrzej Kawecki

Andrzej Kawecki,Oncology,Cardiology,Endocrinology

Edit

Andrzej Kawecki

Publications: 41 | Citations: 193

Fields: Oncology, Cardiology, Endocrinology

Collaborated with 132 co-authors from 1993 to 2011 | Cited by 904 authors

Cumulative Annual

Sort by:

Publications (41)

BibTeX | RIS | RefWorks Download

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49214022&selfId1=23845785&selfId2=0&maxNumber=12&query=

Journal: Radiotherapy and Oncology - RADIOTHER ONCOL , vol. 100, no. 1, pp. 62-69, 2011

Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villous Sampling and Fetal Blood Sampling

, , , , , , , , ,

Journal: Ultrasound in Medicine and Biology - ULTRASOUND MED BIOL , vol. 37, no. 8, pp. S66-S66, 2011

Hypoplastic Left Heart and Changes of Fetal Precardiac Venous Flow Patterns During Pregnancy

, , , , , ,

Journal: Ultrasound in Medicine and Biology - ULTRASOUND MED BIOL , vol. 37, no. 8, pp. S10-S10, 2011

Zastosowanie techniki SIB-IMRT w leczeniu skojarzonym z jednoczesną chemioterapią u chorych na nowotwory głowy i szyi w III i IVa stopniu zaawansowania. Ocena wczesnych wyników i tolerancji leczenia

, , , ,

Journal: Journal of Electrocardiology - J ELECTROCARDIOL , vol. 65, no. 5, pp. 117-125, 2011

Ocena wyników i tolerancji zachowawczego leczenia oszczędzającego narząd u chorych na lokoregionalnie zaawansowanego raka krtani i krtaniowej części gardła

, , , ,

Journal: Journal of Electrocardiology - J ELECTROCARDIOL , vol. 65, no. 5, pp. 363-368, 2011

Sort by:

Citations (193 times by 191 publications)

Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

, , , , ,

Journal: PLOS One , vol. 7, no. 6, 2012

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus

, , , , , , ,

Journal: Cancer Gene Therapy , vol. 19, no. 3, pp. 181-191, 2012

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618 (Citations: 3)

, , , , , ,

Journal: Investigational New Drugs - INVEST NEW DRUG , vol. 29, no. 2, pp. 352-359, 2011

Gefitinib in Combination With Irradiation With or Without Cisplatin in Patients With Inoperable Stage III Non–Small Cell Lung Cancer: A Phase I Trial (Citations: 2)

, , , , , , , , , ,

Journal: International Journal of Radiation Oncology Biology Physics - INT J RADIAT ONCOL BIOL PHYS , vol. 80, no. 1, pp. 126-132, 2011

Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity (Citations: 2)

, , , ,

Journal: Immunologic Research - IMMUNOL RES , vol. 50, no. 2, pp. 248-254, 2011

Comments

Co-authors (132)

Journals (12)

Keywords (26)

Andrzej Kawecki,Oncology,Cardiology,Endocrinology

Publications (41)

BibTeX | RIS | RefWorks Download

Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: A phase II, randomized, double-blind, placebo-controlled study

Fetal Loss Rate and Associated Risk Factors After Amniocentesis, Chorionic Villous Sampling and Fetal Blood Sampling

Hypoplastic Left Heart and Changes of Fetal Precardiac Venous Flow Patterns During Pregnancy

Zastosowanie techniki SIB-IMRT w leczeniu skojarzonym z jednoczesną chemioterapią u chorych na nowotwory głowy i szyi w III i IVa stopniu zaawansowania. Ocena wczesnych wyników i tolerancji leczenia

Ocena wyników i tolerancji zachowawczego leczenia oszczędzającego narząd u chorych na lokoregionalnie zaawansowanego raka krtani i krtaniowej części gardła

Citations (193 times by 191 publications)

Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618 (Citations: 3)

Gefitinib in Combination With Irradiation With or Without Cisplatin in Patients With Inoperable Stage III Non–Small Cell Lung Cancer: A Phase I Trial (Citations: 2)

Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity (Citations: 2)


	View FAQ about top research areas and Fields of study

Andrzej Kawecki,Oncology,Cardiology,Endocrinology

Publications (41) BibTeX | RIS | RefWorks Download

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618 (Citations: 3)

Gefitinib in Combination With Irradiation With or Without Cisplatin in Patients With Inoperable Stage III Non–Small Cell Lung Cancer: A Phase I Trial (Citations: 2)

Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity (Citations: 2)

Publications (41)

BibTeX | RIS | RefWorks Download